• Improving blood sugar control in adults with type 2 diabetes mellitus
• Supporting glycemic management when monotherapy is not sufficient
• Adjunct to diet and exercise in type 2 diabetes treatment
• Combination oral therapy for insulin resistance and elevated blood glucose

Metformin helps lower blood glucose by decreasing hepatic glucose production, reducing intestinal glucose absorption, and improving insulin sensitivity. Pioglitazone is a thiazolidinedione that improves insulin sensitivity in muscle and fat tissue, helping the body use insulin more effectively.

Together, these medicines help reduce high blood sugar levels in adults with type 2 diabetes and may support improved long-term glycemic control when used under medical supervision.

• Combination oral treatment for type 2 diabetes
• Helps improve insulin sensitivity
• Supports blood sugar control when diet and exercise alone are not enough
• Combines two complementary antidiabetic medicines in one tablet
• May reduce the need for multiple separate tablets in some patients

Take Metformin / Pioglitazone exactly as prescribed by your healthcare professional. It is commonly taken with meals to help reduce gastrointestinal side effects associated with metformin. Tablets should be swallowed whole with water.

The dose depends on the patient’s current treatment, blood glucose levels, response to therapy, and tolerance. Do not change the dose or stop treatment without medical advice.

This medicine is intended for type 2 diabetes mellitus and is not suitable for type 1 diabetes or diabetic ketoacidosis. Patients should inform their healthcare provider about any history of kidney disease, liver disease, heart failure, bladder cancer, diabetic eye disease, fluid retention, or swelling before starting treatment.

Metformin-containing medicines carry a risk of lactic acidosis, a rare but serious medical condition. Pioglitazone may cause or worsen fluid retention and may not be suitable in some patients with heart failure. Ongoing monitoring may be required during treatment.

Common side effects may include nausea, diarrhea, stomach upset, abdominal discomfort, headache, weight gain, swelling, upper respiratory symptoms, and changes in blood glucose levels. Gastrointestinal symptoms are commonly associated with metformin, especially when treatment is first started.

Patients should seek prompt medical attention if they develop symptoms such as unusual tiredness, breathing difficulty, muscle pain, swelling, rapid weight gain, chest symptoms, blood in the urine, or signs of low blood sugar when used with other diabetes medicines.

Metformin / Pioglitazone may be prescribed for adults with type 2 diabetes who require improved glycemic control and may benefit from combination oral therapy. It may be especially useful in selected patients with insulin resistance when treatment goals are not achieved with lifestyle measures and single-agent therapy alone.

• Product Name: Metformin / Pioglitazone Tablets
• Active Ingredients: Metformin and Pioglitazone
• Drug Classes: Biguanide and Thiazolidinedione
• Dosage Form: Oral tablets
• Route of Administration: Oral
• Prescription Status: Prescription only

Metformin / Pioglitazone tablets provide a convenient oral combination option for eligible adults with type 2 diabetes who require ongoing blood sugar management. When supplied by a licensed pharmacy against a valid prescription, they offer a practical option for long-term diabetes treatment and medication continuity.

This product description is for informational purposes only and does not replace professional medical advice. Metformin / Pioglitazone should only be used under the direction of a qualified healthcare professional.